Savvy Updates 9/3/24: Dexcom/Stelo OTC CGM, Lilly Slashes Zepbound Prices, Personal CGMs Preferred by Patients/Staff, GluFormer AI Models Predict BG Levels, Smart Insulins & Type 1 Diabetes Grand Challenge, Best Exercise for Male/Female T1Ds, PBM Execs Facing Fines/Jail, Beta Bionics Reaches 10,000 iLet Users, Choose Cheese Wisely

Savvy Updates 9/3/24: Dexcom/Stelo OTC CGM, Lilly Slashes Zepbound Prices, Personal CGMs Preferred by Patients/Staff, GluFormer AI Models Predict BG Levels, Smart Insulins & Type 1 Diabetes Grand Challenge, Best Exercise for Male/Female T1Ds, PBM Execs Facing Fines/Jail, Beta Bionics Reaches 10,000 iLet Users, Choose Cheese Wisely

Dexcom prices first over-the-counter glucose monitor by Elise Reuter for MedTechDive.com, 26 August 2024. Diabetes technology company Dexcom began selling its first over-the-counter continuous glucose monitor (CGM) on Monday. The device, called Stelo, will cost $89...
Savvy Updates, 3/25/24:  Humalog Shortage, Glucose Levels Affect Cognition, Once-Weekly Basal Insulin, Time in Tight Range, Cow’s Milk Containing Human Insulin, Time-Restricted Eating & CV Risk, Exercise “Pill”, Metformin & Anti-Hunger Molecule, Clean Your Water Bottle, “Ozempic” Babies

Savvy Updates, 3/25/24: Humalog Shortage, Glucose Levels Affect Cognition, Once-Weekly Basal Insulin, Time in Tight Range, Cow’s Milk Containing Human Insulin, Time-Restricted Eating & CV Risk, Exercise “Pill”, Metformin & Anti-Hunger Molecule, Clean Your Water Bottle, “Ozempic” Babies

Eli Lilly warns of temporary short supply of two insulin products by Meg Tirrell for CNN.com/health, 22 March 2024. Drugmaker Eli Lilly warned that two of its formulations of insulin would be temporarily out of stock through the beginning of April, citing a “brief...
Savvy Updates 6/26/22: Plant-based Oral Insulin, On GLP-1s, Pharma Lobby Sues U.S. Govt., Machine-Learning as BG Controllers, Exercise Difficult for T1Ds, TCOYD on Insulins, TCOYD ONE 2023

Savvy Updates 6/26/22: Plant-based Oral Insulin, On GLP-1s, Pharma Lobby Sues U.S. Govt., Machine-Learning as BG Controllers, Exercise Difficult for T1Ds, TCOYD on Insulins, TCOYD ONE 2023

Is plant-based, oral insulin within reach for diabetes treatment? by Paul Ian Cross for MedicalNewsToday.com, 21 June 2023.   New research, published in the journal Biomaterials, suggests that a plant-based oral delivery method of proinsulin could...
Savvy Updates 4/17/23: ChatGPT as Diabetes Educator, Undbio Korean Insulin Comes to W. VA, 8000 Brisk Steps/Day, Blueberries, GoBag/DayPack, Who’s in Control in the Hospital?

Savvy Updates 4/17/23: ChatGPT as Diabetes Educator, Undbio Korean Insulin Comes to W. VA, 8000 Brisk Steps/Day, Blueberries, GoBag/DayPack, Who’s in Control in the Hospital?

Can ChatGPT Replace Diabetes Educators? Perhaps Not Yet by Liam Davenport for MedScape.com, 14 April 2023.   ChatGPT, the novel artificial intelligence (AI) tool that has attracted interest and controversy in seemingly equal measure, can provide clear and...
Savvy Updates 1/30/23:  Tidepool Loop, EOL for Omnipod Eros, Insulet Data Leak, Dr. Matthias von Herrath at DRI, Rockley Folds, Getting Enough Exercise?, Platinum Rule of Patient Care

Savvy Updates 1/30/23: Tidepool Loop, EOL for Omnipod Eros, Insulet Data Leak, Dr. Matthias von Herrath at DRI, Rockley Folds, Getting Enough Exercise?, Platinum Rule of Patient Care

Tidepool Announces FDA Clearance of Tidepool Loop was released on 24 January 2023.   Tidepool, a 501(c)3 nonprofit committed to empowering the next generation of innovations in diabetes management, announced the FDA clearance of Tidepool Loop, an...
Skip to content